ASLAN Pharmaceuticals Limited announced the appointment of Alex Kaoukhov, MD, as Chief Medical Officer based in ASLAN's US office, effective immediately. Alex was most recently Head of Clinical Development, Senior Vice President at Bioniz Therapeutics where he established and managed a team responsible for the development of therapeutic assets for the treatment of skin and gastrointestinal autoimmune diseases. Prior to this, from 2018 to 2020, Alex served as Head of Global Development at Almirall.

His responsibilities included global clinical and non-clinical development, in addition to contributing to business development activities relating to building out the company's medical dermatology pipeline, including the in-licensing of lebrikizumab for Europe.